ConductScience.org, home

Paper42865622PubMed

FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms.

Abuduaini D and 4 others. Front Oncol, 2026.

Cite this record

ConductScience Library. FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms. Papers, record 42865622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42865622

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms.
Journal
Front Oncol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-14

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abuduaini DDiyaer
2Simayi DDiernu
3Maimaiti MMihelayi
4Feng YYinglan
5Wang YYixia

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134390367Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.Ann Hematol2021https://conductscience.org/library/papers/34390367PubMed
220427518ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.Bioinformatics2010https://conductscience.org/library/papers/20427518PubMed
322455463clusterProfiler: an R package for comparing biological themes among gene clusters.OMICS2012https://conductscience.org/library/papers/22455463PubMed
425822800Robust enumeration of cell subsets from tissue expression profiles.Nat Methods2015https://conductscience.org/library/papers/25822800PubMed
522375971A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.N Engl J Med2012https://conductscience.org/library/papers/22375971PubMed
633597522Inference and analysis of cell-cell communication using CellChat.Nat Commun2021https://conductscience.org/library/papers/33597522PubMed
726951227Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.Cancer Discov2016https://conductscience.org/library/papers/26951227PubMed
824325359Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.N Engl J Med2013https://conductscience.org/library/papers/24325359PubMed
939383242A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.Sci Transl Med2024https://conductscience.org/library/papers/39383242PubMed
1026668133Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.Blood2016https://conductscience.org/library/papers/26668133PubMed
1135298263Copper induces cell death by targeting lipoylated TCA cycle proteins.Science2022https://conductscience.org/library/papers/35298263PubMed
1232386542Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.Mol Cell2020https://conductscience.org/library/papers/32386542PubMed
1331270458Somatic mutations and cell identity linked by Genotyping of Transcriptomes.Nature2019https://conductscience.org/library/papers/31270458PubMed
1415781101Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.Lancet2005https://conductscience.org/library/papers/15781101PubMed
1526854026Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.Leukemia2016https://conductscience.org/library/papers/26854026PubMed
1615793561A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.Nature2005https://conductscience.org/library/papers/15793561PubMed
1720808728Regularization Paths for Generalized Linear Models via Coordinate Descent.J Stat Softw2010https://conductscience.org/library/papers/20808728PubMed
1821300928Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.J Clin Oncol2011https://conductscience.org/library/papers/21300928PubMed
1935732831The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732831PubMed
2034062119Integrated analysis of multimodal single-cell data.Cell2021https://conductscience.org/library/papers/34062119PubMed

See all 31 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42865622

GET https://conductscience.org/api/papers/v1/42865622/references?page=2